Patient-Centricity Infused into Shaare Zedek Imminent New Cancer Center & Radiotherapy Institute

Patient-Centricity Infused into Shaare Zedek Imminent New Cancer Center & Radiotherapy Institute

Shaare Zedek Medical Center and the new Cancer Center and Radiotherapy Institute, currently under construction, will usher in the patient-centric paradigm of whole-person, comprehensive cancer care. An advanced clinical investigational site as well, Shaare Zedek Medical conducts approximately 160 clinical trials each year.

Comprehensive Cancer Care

Upon the first stage of diagnosis (radiology department) to surgery, medical oncology, cancer genetics, fertility preservation, and even psycho-social support, palliative care and survivorship care, Shaare Zedek Medical Center is preparing for a patient-centric model that establishes the standard.

A Holistic Approach

Shaare Zedek fully embraces patient-centricity via both physical care as well as the psychological and social aspects of the disease. Shani Paluch-Shimon, director of their Oncology Department in Jerusalem noted: “Our approach is a holistic one that is based on patient needs and takes into account all aspects of the patient’s care.”

Clinical Research as a Care Option

Shaare Zedek has fully embraced the use of clinical trials as a way to accelerate targeted treatments to those cancer patients in dire need. The number of clinical trials for evaluating new drugs at Shaare Zedek has tripled at the center in the last year alone Dr. Paluch-Simon reports. This expansion of clinical research as a care option has afforded oncology patients with heretofore not practical choices to access highly advanced and promising investigational cancer therapies and treatments. 

The Director

Shani-Paluch-Shimon, Director of Oncology Department

Call to Action: TrialSite News has many readers in Israel. Be aware of the new Shaare Zedek Medical Center and new Cancer Center and Radiotherapy Institute as when construction is complete it will represent the cutting-edge of patient care. Global biopharma companies should consider partnering with Shaare Zedek to better understand how providers and Sites are reorganizing with the patient in mind!